These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21498307)

  • 1. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI.
    Amano Y; Takayama M; Fukushima Y; Kitamura M; Kumita S
    Acta Radiol; 2011 Jul; 52(6):613-8. PubMed ID: 21498307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
    Kim YJ; Choi BW; Hur J; Lee HJ; Seo JS; Kim TH; Choe KO; Ha JW
    J Magn Reson Imaging; 2008 May; 27(5):1054-60. PubMed ID: 18425835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of apical left ventricular aneurysm and thinning associated with hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Comput Assist Tomogr; 2008; 32(2):259-64. PubMed ID: 18379313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
    Sueyoshi E; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis.
    Debl K; Djavidani B; Buchner S; Lipke C; Nitz W; Feuerbach S; Riegger G; Luchner A
    Heart; 2006 Oct; 92(10):1447-51. PubMed ID: 16606864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.
    Selvanayagam JB; Kardos A; Francis JM; Wiesmann F; Petersen SE; Taggart DP; Neubauer S
    Circulation; 2004 Sep; 110(12):1535-41. PubMed ID: 15353496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy.
    Amano Y; Kumita S; Takayama M; Kumazaki T
    AJR Am J Roentgenol; 2005 Aug; 185(2):312-8. PubMed ID: 16037498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
    Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity.
    Dodd JD; Holmvang G; Hoffmann U; Ferencik M; Abbara S; Brady TJ; Cury RC
    AJR Am J Roentgenol; 2007 Oct; 189(4):974-80. PubMed ID: 17885073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy.
    Doesch C; Huck S; Böhm CK; Michaely H; Fluechter S; Haghi D; Dinter D; Borggrefe M; Papavassiliu T
    Magn Reson Imaging; 2010 Jul; 28(6):812-9. PubMed ID: 20409668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.